echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > eLife: Significant findings have been made in the study of fatal muscular dystrophy diseases

    eLife: Significant findings have been made in the study of fatal muscular dystrophy diseases

    • Last Update: 2022-09-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Doo's muscular dystrophy (DMD) is caused by a genetic mutation that affects one in every 5,000 boys born
    .


    Children with this condition require a wheelchair as a teenager, and most will die
    in their 30s or 30s.


    Previously, it was widely believed that DMD began with muscle fibers – cells involved in contraction that make up the body
    of all muscles.


    New research suggests that the disease begins earlier
    in cells destined to become muscle fibers, known as myoblasts.


    The study, published in eLife, is part of an ongoing collaboration between scientists from the University of Portsmouth, the French National Centre for Scientific Research, I-STEM, AFM France and the main pharmacological institutes of the Polish Academy of Sciences

    Professor Darek Gorecki, senior author from the University of Portsmouth's School of Pharmacy and Biological Sciences, said: "These findings are significant because they change the way
    we understand this disease.


    "Because these myogenic cells are dysfunctional, damaged muscles cannot be repaired
    effectively.


    Last year, the team released the results of DMD modeling, looking at its development in terms of
    its initial triggers and initial performance.


    Professor Gorecki added: "At the moment, we are targeting the late stages of the disease, treating teenage patients at a time when muscle degeneration has already caused them harm
    .


    "Conversely, if we try to correct cells at the beginning of the pathological process, we may be able to delay muscle degeneration and extend the patient's lifespan
    .


    The paper says the new technology could be the key
    to producing effective therapies for this devastating disease.


    essay

    Loss of full-length dystrophin expression results in major cell-autonomous 2 abnormalities in proliferating myoblasts


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.